Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Kortmansky · SciRah

Researcher profile · Semantic Scholar

J. Kortmansky

Share profile

J. Kortmansky — researcher profile on SciRah

h-index: 19
Works: 67
Citations: 2,979

Most-cited papers

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial.
C. Eng, T. W. Kim, J. Bendell, G. Argilés +75 more
2019The Lancet Oncology480 citations Open access
Semantic Scholar
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline.
John D. Gordan, E. Kennedy, G. Abou-Alfa, M. S. Beg +23 more
2020Journal of Clinical Oncology477 citations
Semantic Scholar
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas
I. Duran, J. Kortmansky, Darshan Singh, H. Hirte +14 more
2006British Journal of Cancer314 citations Open access
Semantic Scholar
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update
J. Gordan, E. Kennedy, G. Abou-Alfa, Eliza W. Beal +20 more
2024Journal of Clinical Oncology279 citations Open access
Semantic Scholar
Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313.
R. K. Ramanathan, Shannon L. McDonough, P. Philip, S. Hingorani +11 more
2019Journal of Clinical Oncology255 citations Open access
Semantic Scholar
Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer
S. Stein, E. James, Yan-ming Deng, Xiangyu Cong +11 more
2016British Journal of Cancer198 citations Open access
Semantic Scholar
Bryostatin-1: A Novel PKC Inhibitor in Clinical Development
J. Kortmansky, G. Schwartz
2003Cancer Investigation166 citations
Semantic Scholar
Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with Fluorouracil in patients with advanced solid tumors.
J. Kortmansky, M. Shah, A. Kaubisch, Amanda R. Weyerbacher +11 more
2005Journal of Clinical Oncology104 citations
Semantic Scholar
Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor.
A. Seidman, R. Portenoy, T. Yao, J. Lepore +13 more
1995Journal of the National Cancer Institute103 citations
Semantic Scholar
A Phase I Clinical Trial of the Sequential Combination of Irinotecan Followed by Flavopiridol
M. Shah, J. Kortmansky, M. Motwani, M. Drobnjak +11 more
2005Clinical Cancer Research98 citations Open access
Semantic Scholar
A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma.
A. Duffy, J. Kortmansky, G. Schwartz, M. Capanu +5 more
2008Annals of Oncology79 citations Open access
Semantic Scholar
A Phase 2 Study of Flavopiridol (Alvocidib) in Combination with Docetaxel in Refractory, Metastatic Pancreatic Cancer (NCI#6366)
R. Carvajal, A. Tse, M. Shah, R. Lefkowitz +6 more
2009Pancreatology (Print)48 citations Open access
Semantic Scholar
The cyclin-dependent kinase inhibitor flavopiridol potentiates gamma-irradiation-induced apoptosis in colon and gastric cancer cells.
Christoph Jung, M. Motwani, J. Kortmansky, F. Sirotnak +4 more
2003Clinical Cancer Research48 citations
Semantic Scholar
Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer
M. Cecchini, Ronald R. Salem, Marie E. Robert, Suzanne Czerniak +31 more
2024JAMA Oncology39 citations Open access
Semantic Scholar
A phase IB/II randomized study of mFOLFIRINOX (mFFOX) + pegylated recombinant human hyaluronidase (PEGPH20) versus mFFOX alone in patients with good performance status metastatic pancreatic adenocarcinoma (mPC): SWOG S1313 (NCT #01959139).
R. Ramanathan, Shannon L. McDonough, P. Philip, S. Hingorani +11 more
201824 citations
Semantic Scholar
Tandem high-dose influenza vaccination is associated with more durable serologic immunity in patients with plasma cell dyscrasias
A. Branagan, Eamon Y. Duffy, Ge-Liang Gan, Fang-Yong Li +12 more
2021Blood Advances21 citations Open access
Semantic Scholar
Interim analysis of a phase II study of dose-modified FOLFIRINOX (mFOLFIRINOX) in locally advanced (LAPC) and metastatic pancreatic cancer (MPC).
E. James, Xiaopan Yao, Xiangyu Cong, Jia Li +10 more
201421 citations
Semantic Scholar
Pembrolizumab Plus mFOLFOX7 or FOLFIRI for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer: KEYNOTE-651 Cohorts B and D.
Richard Kim, M. Tehfé, P. Kavan, Jorge Chaves +12 more
2024Clinical colorectal cancer20 citations
Semantic Scholar
Final analysis of a phase II study of Yale-modified FOLFIRINOX (mFOLFIRINOX) in metastatic pancreatic cancer (MPC).
E. James, Xiangyu Cong, Xiaopan Yao, C. Hahn +9 more
201520 citations
Semantic Scholar
A phase I trial of erlotinib, gemcitabine and radiation for patients with locally advanced, unresectable pancreatic cancer
J. Kortmansky, E. O'Reilly, B. Minsky, S. Puleio +3 more
200516 citations
Semantic Scholar
Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national cancer database analysis
J. Miccio, W. Talcott, Timil H. Patel, Henry S. Park +12 more
2020Clinical and Translational Radiation Oncology13 citations Open access
Semantic Scholar
MORPHEUS: A phase Ib/II study platform evaluating the safety and clinical efficacy of cancer immunotherapy (CIT)–based combinations in gastrointestinal (GI) cancers.
J. Desai, J. Kortmansky, N. Segal, M. Fakih +16 more
2019Journal of Clinical Oncology12 citations
Semantic Scholar
A phase I study of weekly irinotecan (CPT), cisplatin (CIS) and flavopiridol (F).
M. Shah, J. Kortmansky, Mithat Gonen, A. Tse +6 more
2004Journal of Clinical Oncology12 citations
Semantic Scholar
Multicenter phase II study of Cabazitaxel in advanced gastroesophageal cancer: Association of HER2 Expression and M2-like Tumor Associated Macrophages with Patient Outcome
M. Shah, P. Enzinger, Andrew H. Ko, A. Ocean +21 more
2020Clinical Cancer Research11 citations Open access
Semantic Scholar
A Phase 1b Expansion Study of TAS-102 With Oxaliplatin For Refractory Metastatic Colorectal Cancer
M. Cecchini, J. Kortmansky, Can Cui, Wei Wei +10 more
2020Cancer11 citations Open access
Semantic Scholar
Phase II Study of Modified FOLFOX6 With Bevacizumab in Metastatic Gastroesophageal Adenocarcinoma
Jia Li, Xiaopan Yao, J. Kortmansky, N. Fischbach +7 more
2017American Journal of Clinical Oncology10 citations
Semantic Scholar
NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma
M. Cecchini, J. Cleary, Yu Shyr, Joseph Chao +19 more
2023British Journal of Cancer9 citations Open access
Semantic Scholar
Pembrolizumab (pembro) plus mFOLFOX or FOLFIRI in patients with metastatic colorectal cancer (mCRC): KEYNOTE-651 cohorts B and D
R. Kim, J. Chaves, P. Kavan, M. Fakih +9 more
2019Annals of Oncology9 citations Open access
Semantic Scholar
Measuring the Impact of Academic Cancer Network Development on Clinical Integration, Quality of Care, and Patient Satisfaction.
A. Chiang, J. Lake, N. Sinanis, D. Brandt +18 more
2018Journal of Oncology Practice8 citations Open access
Semantic Scholar
A phase II trial of temsirolimus in metastatic neuroendocrine carcinomas (NECs)
I. Durán, L. Lê, D. Saltman, J. Kortmansky +6 more
20058 citations
Semantic Scholar
Pembrolizumab Plus Binimetinib With or Without Chemotherapy for MSS/pMMR Metastatic Colorectal Cancer: Outcomes From KEYNOTE-651 Cohorts A, C, and E.
E. Chen, P. Kavan, M. Tehfé, J. Kortmansky +12 more
2024Clinical colorectal cancer6 citations
Semantic Scholar
Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer
M. Cecchini, Janie Y. Zhang, Wei Wei, J. Sklar +12 more
2023Cancer Research Communications6 citations Open access
Semantic Scholar
A phase I study of TAS-102 in combination with oxaliplatin (TAS-OX) for refractory metastatic colorectal cancer (mCRC).
M. Cecchini, J. Kortmansky, J. Lacy, N. Fischbach +6 more
2019Journal of Clinical Oncology6 citations
Semantic Scholar
Randomized trial of irinotecan and cetuximab (IC) versus irinotecan, cetuximab and ramucirumab (ICR) as 2nd line therapy of advanced colorectal cancer (CRC) following oxaliplatin and bevacizumb based therapy: Result of E7208.
H. Hochster, P. Catalano, P. O'Dwyer, E. Mitchell +8 more
2018Annals of Oncology6 citations Open access
Semantic Scholar
A Phase 2 study of Savolitinib in Patients with MET Amplified Metastatic Colorectal Cancer
Jingquan Jia, Ashley N Moyer, Melissa E. Lowe, Emily Bolch +6 more
2024Journal of Gastrointestinal Cancer5 citations Open access
Semantic Scholar
493P Pembrolizumab (pembro) plus mFOLFOX7 or FOLFIRI in patients (pts) with metastatic colorectal cancer (mCRC): Updated results from KEYNOTE-651 cohorts B and D
R. Kim, J. Chaves, P. Kavan, M. Fakih +8 more
20205 citations Open access
Semantic Scholar
A phase I dose finding study of weekly, sequential docetaxel (Doc) followed by flavopiridol (F) in patients with advanced solid tumors
D. Rathkopf, M. Fornier, M. Shah, J. Kortmansky +6 more
20045 citations
Semantic Scholar
Pre-operative chemoradiotherapy with or without induction chemotherapy for operable locally-advanced esophageal cancer
G. W. Peters, W. Talcott, N. Peters, A. Dhanasopan +9 more
2023Journal of Gastrointestinal Oncology4 citations Open access
Semantic Scholar
A Single-Institution Experience of Induction 5-Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin Followed by Surgery Versus Consolidative Radiation for Borderline and Locally Advanced Unresectable Pancreatic Cancer
M. Cecchini, J. Miccio, Jay K. Pahade, J. Lacy +6 more
2020Pancreas4 citations
Semantic Scholar
Management of hyperglycemia in patients with metastatic pancreatic cancer receiving UCN-01 and fluorouracil.
J. Kortmansky, N. Sauter, E. O'Reilly, M. Shah +6 more
2004Journal of Clinical Oncology4 citations
Semantic Scholar
A single arm phase 2 clinical trial of YIV-906 with neoadjuvant concurrent chemo-radiation therapy in patients with locally advanced rectal cancer
Nipun Verma, K. Johung, J. Kortmansky, W. Zaheer +9 more
2024Journal of Gastrointestinal Oncology3 citations Open access
Semantic Scholar
A phase I clinical and pharmacokinetic study of weekly docetaxel followed by flavopiridol: promising activity in metastatic pancreatic cancer
D. Rathkopf, M. Fornier, M. Shah, J. Kortmansky +5 more
20053 citations
Semantic Scholar
Implementing the cancer and aging research group (CARG) tool in the ambulatory oncology setting to drive informed treatment selection.
Alexander Mbewe, Paula Pike, Russell S. Lewis, J. Kortmansky +2 more
2021Journal of Clinical Oncology2 citations
Semantic Scholar
259 Phase Ib/II open-label, randomized evaluation of atezolizumab (atezo) + selicrelumab (seli) + gemcitabine+nab-paclitaxel (gem+nabP) or bevacizumab (bev) vs control in MORPHEUS-PDAC, -TNBC and -CRC
G. Manji, Nathan Bahary, V. Chung, F. Dalenc +15 more
2020Journal for ImmunoTherapy of Cancer2 citations Open access
Semantic Scholar
Phase II study of Yale modified FOLFIRINOX (mFOLFIRINOX) in locally advanced pancreatic cancer (LAPC).
S. Stein, Xiangyu Cong, Xiaopan Yao, C. Hahn +7 more
20152 citations
Semantic Scholar
Phase II study of mFOLFOX6 with bevacizumab (Bev) in metastatic gastric and esophageal (GE) adenocarcinoma.
Jia Li, J. Kortmansky, M. Saif, N. Fischbach +5 more
20102 citations
Semantic Scholar
A phase I dose finding study of weekly, sequential docetaxel (Doc) followed by flavopiridol (F) in patients with advanced solid tumors.
D. Rathkopf, M. Fornier, M. Shah, J. Kortmansky +6 more
2004Journal of Clinical Oncology2 citations
Semantic Scholar
Abstract CT170: A phase 1/2 study of olaparib in combination with ramucirumab in metastatic gastric and gastroesophageal junction adenocarcinoma (GEJ)
M. Cecchini, J. Chao, Y. Shyr, James Cleary +15 more
2022Cancer Research1 citations
Semantic Scholar
Pembrolizumab (pembro) plus binimetinib (bini) with or without chemotherapy (chemo) for metastatic colorectal cancer (mCRC): Results from KEYNOTE-651 cohorts A, C, and E.
E. Chen, P. Kavan, M. Tehfé, J. Kortmansky +12 more
2022Journal of Clinical Oncology1 citations
Semantic Scholar
Outcomes for patients with borderline resectable (BR) and locally advanced (LA) pancreatic cancer (PC) treated with induction FOLFIRINOX (FFX) +/- radiation (RT) followed by surgery compared to induction FFX followed by consolidative RT.
M. Cecchini, J. Miccio, Jay K. Pahade, J. Lacy +5 more
2019Journal of Clinical Oncology1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Lacy×19
Invite
J. Lacy — researcher profile on SciRah
S. Stein×14
Invite
S. Stein — researcher profile on SciRah
D. Kelsen×10
Invite
D. Kelsen — researcher profile on SciRah
M. Cecchini×10
Invite
M. Cecchini — researcher profile on SciRah

×9

Invite

G. Schwartz — researcher profile on SciRah

Invite

E. O'Reilly — researcher profile on SciRah

Invite

H. Hochster — researcher profile on SciRah

Invite

E. Chiorean — researcher profile on SciRah

Invite

R. Salem — researcher profile on SciRah

Invite

M. Shah — researcher profile on SciRah

Invite

K. Johung — researcher profile on SciRah

Jaykumar Thumar×6

Invite

Jaykumar Thumar — researcher profile on SciRah